Gordon Carl L: insider buys
Every open-market stock purchase reported by Gordon Carl L to the SEC on Form 4.
Total bought$61.15M
Purchases4
Companies4
Last purchase filedSep 30, 2026
Return on these buys-17%
Gordon Carl L has made 4 open-market purchases worth $61.15M in 4 companies since Jul 29, 2026, according to SEC Form 4 filings. The most recent was filed on Sep 30, 2026: 950,000 shares of ADRX at $17.00 (Director, 10% Owner), worth $16.15M. The largest was $20M of ETRA on Sep 21, 2026. Taken together, these purchases are down 17% at the latest closing prices (split-adjusted, weighted by amount).
Companies Gordon Carl L bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| ETRA | Electra Therapeutics, Inc. | Director, 10% Owner | 1 | $20M | -46% | Sep 23 |
| ADRX | ADARx Pharmaceuticals, Inc. | Director, 10% Owner | 1 | $16.15M | +0.0% | Sep 30 |
| SCTX | Scribe Therapeutics, Inc. | Director | 1 | $15M | +2.8% | Jul 29 |
| BLSM | BlossomHill Therapeutics, Inc. | Director | 1 | $10M | -14% | Aug 12 |
Get the next Gordon Carl L purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30 | ADRXADARx Pharmaceuticals, Inc. | Gordon Carl LDirector, 10% Owner | $16.15M | 950,000 | $17.00 | +0.0% | +11% | Sep 28 | SEC |
| Sep 23 | ETRAElectra Therapeutics, Inc. | Gordon Carl LDirector, 10% Owner | $20M | 1,333,333 | $15.00 | -46% | +314% | Sep 21 | SEC |
| Aug 12 | BLSMBlossomHill Therapeutics, Inc. | Gordon Carl LDirector | $10M | 625,000 | $16.00 | -14% | +30% | Aug 10 | SEC |
| Jul 29 | SCTXScribe Therapeutics, Inc. | Gordon Carl LDirector | $15M | 1,000,000 | $15.00 | +2.8% | +287% | Jul 27 | SEC |